Overview

A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if it is safe and effective to give Viracept to AIDS patients who are being treated for MAC.
Phase:
Phase 2
Details
Lead Sponsor:
Agouron Pharmaceuticals
Treatments:
Nelfinavir